It helps identify active CMV infection, monitor disease progression, and evaluate treatment effectiveness in high-risk patients.

It indicates active infection or viral replication, requiring medical attention and possibly antiviral treatment.

It suggests controlled infection, effective treatment, or absence of significant viral activity.

Yes, newborns and children can undergo the test if clinically indicated, especially in suspected congenital CMV infection.

Antiviral drugs may lower CMV DNA levels, reflecting treatment effectiveness rather than false results.

Yes, levels fluctuate with infection activity and treatment response, so repeat testing is often needed.